Dr Lalchandani Labs Limited IPO Review (Date, Price)

Dr Lalchandani Labs Limited IPO Review

Dr Lalchandani Labs Limited (DLLL) is a provider of diagnostic and related healthcare tests. It is Delhi based company. This company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. DLLL is coming up with their initial public offering that wi hit the primary markets on 25th of April. We will post the Dr Lalchandani Labs Limited IPO Review based on their draft red herring prospectus, issue date, issue price and other issue details.

About Dr Lalchandani Labs Limited IPO :

  • IPO Opens on – April 25, 2018.
  • IPO Closes on – April 27, 2018.
  • Face Value – Rs. 10 Per Equity Share.
  • Issue Price – Rs. 30 Per Equity Share.
  • Issue Type – Fixed Price Issue IPO.
  • Market Lot – 4000 Shares.
  • Minimum Order Quantity – 4000 Shares.
  • Issue Size – 1,400,000 Equity Shares of Rs 10 aggregating up to Rs 4.20 Cr.
  • Listing Exchange – BSE SME Exchange.
  • Draft Prospectus – Click Here.

Objectives of the issue:

  • To open second major processing center (2000 sq. ft. area) in Delhi/NCR.
  • Repayment/pre-payment, in full or part, of certain borrowings availed by this company.
  • To purchase advanced machinery and equipment.
  • To open new collection centers based on COCO model.
  • To develop E Applications and E Programs and other I.T. support system.
  • For Recruitment, Training and Placement of staff to expand operations and other operational expenses.
  • For general corporate purposes.

About The Company –

  • Dr Lalchandani Labs Limited is incorporated in 2011.
  • This company is managing or servicing labs at some of the leading hospitals and operating retail outlets such as-
  1. Primus Super Specialty Hospital, Chanakyapuri.
  2. Nanda Hospital, Chattarpur (70 Bedded).
  3. Eden Hospital, East of Kailash (25 Bedded).
  4. East of Kailash Retail outlet.
  5. Dr Raturi Hospital, Khatima, Uttrakhand.
  6. Lords Day care Centre, Bhogal New Delhi.
  7. Greater Kailash Part 1 – Retail outlet and Head office.
  8. Lajpat Nagar 2 – Retail Flagship outlet.
  9. Shahdra – Retail outlet.
  10. Dwarka Sector 19 – Retail outlet.
  11. Arya Samaj Mandir Sarojini Nagar- Charitable Retail Outlet.
  12. Arya Samaj Mandir Kalkaji – Charitable Retail outlet.
  13. Arya Samaj Mandir Kasturbha Nagar – Charitable Retail Outlet.
  14. Jampur Bhawan – Charitable Retail outlet.
  15. Laxmi Narayan Mandir Malviya Nagar – Charitable Retail Outlet.
  • In state of the art NABL accredited lab in existence since 28 years with fully automatic machines.
  • This company is maintain robust documentation, control checks and Quality logs as per NABL.
  • Dr Lalchandani Labs reputed suppliers such as Johnson & Johnson, Roche, Nicholas Piramal etc.
  • This company ability to process 1000 samples/hour with same day reporting.
  • Regulary participate in EQAS (External Quality Assurance Service) with prestigious institutes like AIIMS, Vellore and Sir Ganga Ram Hospital.

Dr Lalchandani Labs Limited

Dr Lalchandani Labs Limited

Dr Lalchandani Labs Limited

Promoters of the company :

  • Mr. Arjan Lal Chandani, aged 65 years, is the Promoter and Managing
    Director of this company.
  • Mr. Mohit Lal Chandani, aged 31 Years, is the Promoter and Whole-Time
    Director of this company.
  • Mrs. Anchal Gupta, aged 31 years, is a Non Executie and Non Independent
    Director of this company.

Company Financials:

Dr Lalchandani Labs Limited IPO

Dr Lalchandani Labs Limited IPO Review:

The company has shown an increase in the profitability year after year starting from the financial year 2013. After the company got converted into a limited company only on the financial year 2018, their earnings per share have been recorded just above 1. The issue looks fully priced at the issue price of Rs. 30 per equity share. The company has lower PE ratio than industry peers like Dr Lal Path Lab or Thyrocare etc. Hence, our Dr Lalchandani Labs Limited IPO Review has a POSITIVE view on this pully priced issue. One can invest in DLLL with a long-term view.

Dr Lalchandani Labs Limited IPO Review (Date, Price)

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to top